Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Urol Rep. 2012 Feb;13(1):38-46. doi: 10.1007/s11934-011-0225-x.

Role of cytoreductive nephrectomy in the era of targeted therapy for renal cell carcinoma.

Author information

1
Department of Surgery, University of Kentucky, Lexington, KY 40513, USA.

Abstract

With the advent of targeted therapy for the treatment of metastatic renal cancer, the routine use of cytoreductive nephrectomy has been questioned. However, available data suggest that cytoreductive nephrectomy remains an integral part of treatment in properly selected patients. This review details the rationale for the continued use of cytoreductive nephrectomy in acceptable surgical candidates in the era of targeted therapy.

PMID:
22105577
DOI:
10.1007/s11934-011-0225-x
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center